TAN, Kaiquan and Martin HARAZIM. Association between premorbid beta-blocker exposure and sepsis outcomes—the beta-blockers in European and Australian/American septic patients (BEAST) study. Critical Care Medicine. Lippincott Williams & Wilkins, 2022, 49(9), No 9, p. 1493-1503, 1600 pp. ISSN 0090-3493. Available from: https://dx.doi.org/10.1097/CCM.0000000000005034.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Association between premorbid beta-blocker exposure and sepsis outcomes—the beta-blockers in European and Australian/American septic patients (BEAST) study
Authors TAN, Kaiquan and Martin HARAZIM.
Edition Critical Care Medicine, Lippincott Williams & Wilkins, 2022, 0090-3493.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30221 Critical care medicine and Emergency medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.800
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/CCM.0000000000005034
UT WoS 000687033000021
Keywords in English beta-blockers;mortality;organ dysfunction;sepsis;Sequential Organ Failure Assessment score
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 28/6/2023 08:27.
Abstract
Retrospective observational study - β-blocker exposure prior to sepsis, especially to noncardioselective β blockers, may be associated with better outcome in septic patients
PrintDisplayed: 21/7/2024 16:25